Stockreport

BioCardia Reports 2024 Business Highlights and Financial Results

BioCardia, Inc.  (BCDA) 
PDF SUNNYVALE, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardio [Read more]